Key result
Review outlines the mechanisms and clinical implications of prosthetic valve thrombosis following TAVR and SAVR.
Why the study?
The value of long-term anticoagulation to prevent thromboembolism after bioprosthetic heart valve replacement is uncertain, and bioprosthetic valve thrombosis presents an ongoing risk and potential cause of dysfunction.
This review summarizes data on prosthetic valve thrombosis, its pathophysiological mechanisms, and implications in the era of transcatheter valve replacement.
No takes yet. Share an insight, caveat, or question.
May warrant vigilance for early thromboembolism after bioprosthetic valve implantation; leaves open long-term anticoagulation necessity.
Dangas et al. (2016) conducted a review in Prosthetic Heart Valve Thrombosis. Prosthetic heart valves was evaluated. This review outlines the pathophysiological mechanisms of prosthetic valve thrombosis and its clinical implications for patients undergoing transcatheter and surgical valve replacement.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: